ANGLONORDIC LIFE SCIENCE CONFERENCE
Why participate?
This is one of the main meetings of investors and companies in the European biopharmaceutical sector. All of them interested in learning about the Spanish life sciences ecosystem and companies in the industry that offer interesting solutions.
The event includes a calendar of technical and academic sessions, as well as a one2one meeting area and a specific area for presenting companies to investors.
What does ICEX-Invest in Spain offer to startups?
The profiles of the Spanish companies presented will be sent to the organisers of the ANGLONORDIC LIFE SCIENCE CONFERENCE so that they can select a maximum of 10 companies that will have the opportunity to present their project to the investors present there.
The selected companies will be entitled to:
- A delegate pass for the event.
- 20% discount on additional tickets
- 10-minute pitch (including Q&A)
- Company name on the conference website with hyperlink to the company's website
- Profile and access to the B2B meeting organisation platform
- Company profile in the conference programme with speaker's photo and company logo.
- Company and speaker profile with company photo, logo and company description on the online platform.
- Presence on social media
Who is the target audience?
We are looking for Spanish companies in the life sciences sector in the sub-sectors of:
BIOTECH:
• Anti-Infective • Antibodies • Biosimilars • Cell Therapy • Diagnostics • Drug Delivery • Gene Therapy • Generics |
• Microbiome • Nucleic Acid Drugs • Peptides • Proteins • Small Molecules • Stem Cells • Vaccines
|
MEDTECH:
• Anaesthetic and Respiratory Devices • Biomaterials • Coatings • Delivery Devices • Dental Devices • Diagnostic devices • Digital health • Electro Mechanical Medical Devices • Hospital Hardware • Imaging |
• Implantable Devices • Monitoring devices • Ophthalmic and Optical Devices • Patient wellbeing • Radiation Devices • Regenerative Medicine • Reusable Instruments • Single Use Devices • Technical Aids • Technology platforms |
In the following application areas:
• Addiction • Antibiotic resistance • Blood disorders • Cardiovascular • Dermatology • Ear/Eye • Endocrine • Gastrointestinal • Genito-urinary • Immune disorders • Infectious disease |
• Inflammation • Mental health • Muscoloskeletal • Neurodegeneration • Neuropathy • Neuroscience • Oncology • Pain • Pre/Peri-natal • Respiratory • Wellbeing |
Interested?
Send us your Investors deck or presentation in English and in Powerpoint format (pptx) until 17 March to the following addresses: martin.jerch@icex.es and melani.Diaz@icex.es
